查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
2018517

超音波凝胶市场：按产品类型、黏度等级、成分、应用和最终用户划分－2026-2032年全球市场预测

Ultrasound Gels Market by Product Type, Viscosity Level, Ingredient Base, Application, End-User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，超音波凝胶市场价值将达到 1.49 亿美元，到 2026 年将成长到 1.602 亿美元，到 2032 年将达到 2.2046 亿美元，复合年增长率为 5.75%。

主要市场统计数据
基准年 2025 1.49亿美元
预计年份：2026年 1.602亿美元
预测年份 2032 2.2046亿美元
复合年增长率 (%) 5.75%

对超音波凝胶产业现况进行详细概述，重点在于配方、临床整合、供应链韧性和监管关注。

受诊断成像技术进步、临床工作流程演变以及对感染控制日益增长的关注等因素的推动，全球超音波凝胶市场持续发展。超音波凝胶作为换能器与组织之间至关重要但又常被忽视的接触点，其配方、黏度和无菌性直接影响影像品质、患者舒适度和检查效率。随着诊断和治疗性超音波在临床、门诊和兽医诊所等领域的广泛应用，市场需求也不断调整以适应新的使用模式和采购重点。

重大的结构性变化正在重塑临床和兽医超音波应用领域的产品创新、无菌控制和采购偏好。

超音波凝胶市场正经历着变革性的转变，这主要得益于技术和监管重点的融合以及终端用户期望的提高。配备高频换能器的成像系统和携带式床边检测设备的出现，提高了凝胶的性能标准，并刺激了黏度调节和成分选择的创新，以优化声音耦合。同时，对感染控制和一次性使用设备的需求，也使得人们对无菌配方和分装方式的关注度不断提升，这些产品能够最大限度地降低交叉感染的风险，并支持更有效率的临床工作流程。

评估2025年美国关税对原料和供应链结构的影响：驱动采购和在地化调整的因素

美国关税政策将于2025年生效，这将进一步增加依赖跨境供应链获取原材料和成品凝胶产品的製造商、经销商和医疗保健系统的复杂性。对某些聚合物添加剂、界面活性剂和包装组件征收关税，加剧了投入成本的压力，并促使各方重新谈判合约。为此，供应链相关人员正加紧努力实现在地化采购、调整安全库存并重新评估供应商选择流程，以因应未来政策变革带来的影响。

透过详细的細項分析来推动有针对性的产品策略，揭示产品类型、黏度、成分基础、应用和最终用户趋势。

细分市场分析揭示了每个配方和应用类别的清晰性能和应用模式，这些模式决定了产品策略和商业化优先事项。从产品类型来看，非无菌凝胶在常规诊断影像检查领域仍占据主导地位，因为成本和易用性至关重要；而对于介入手术、手术全期以及任何因使用侵入性医疗设备或皮肤损伤而导致感染风险较高的情况，对无菌凝胶的需求正在不断增长。根据黏度水平，高黏度配方因其对垂直表面的黏附性和适用于长时间操作而更受欢迎；中黏度配方为一般诊断应用提供了一种平衡的解决方案；而低黏度凝胶则适用于需要快速探头移动或特定声耦合特性的应用。

美洲、欧洲、中东和非洲以及亚太地区的区域商业性和监管趋势影响着采购、合规和分销策略。

区域趋势正在影响三大主要地区的采购方式、监管合规性和商业化策略。在美洲，庞大且多元化的医院和门诊诊所网路影响着需求模式，这些机构优先考虑无菌标准、成本控制以及快速采用即时检验 (POC) 创新技术。同时，采购框架倾向于采用整合供应商合约和基于价值的采购模式。在欧洲、中东和非洲，复杂的监管环境和多样化的报销机制导致不同市场的采纳曲线各不相同。虽然某些市场强调成分透明度、永续性和遵守特定地区的医疗设备指令，但该地区的新兴市场为具有竞争力的製造商提供了成长机会。

概述策略竞争格局，重点在于全产业的配方差异化、无菌检验、包装创新和伙伴关係机会。

超音波凝胶产业的竞争格局由成熟的製造商、特种化学品公司以及为临床采购商和经销商提供自有品牌解决方案的契约製造製造商组成。业界主要企业优先考虑配方差异化、无菌检验方案以及包装创新，以改善一次性产品的处理并降低污染风险。与影像设备製造商 (OEM) 合作推出联名耗材以及与无菌手术包整合，正成为确保持续需求并加强与销售管道关係的重要策略途径。

切实可行的策略建议，重点在于扩大无菌生产能力、模组化产品组合、多元化供应链以及伙伴关係主导的商业化。

产业领导企业应采取协作方式，将配方创新、法规准备和供应链韧性结合，以保持竞争优势。首先，应优先投资于无菌配方能力和经验证的包装，以支持介入治疗和手术全期应用，从而满足日益增长的感染预防要求，并拓展至更高附加价值的临床领域。其次，应开发模组化产品系列，涵盖高、中、低黏度选项，并利用多种原料，以满足不同的临床偏好，同时提升生产柔软性。

采用严谨的混合调查方法，结合相关人员访谈、监管审查、第二手资料整合和品质保证检查。

本研究采用综合分析方法，透过结构化的研究方法结合一手和二手讯息，确保了稳健且令人信服的证据基础。一手资讯包括对临床采购经理、影像科室经理、药物科学家和供应链主管的访谈，揭示了当前的优先事项、挑战和营运限制。除了这些一线观点外，本研究还回顾了监管指南、生物相容性和无菌标准，以及关于超音波影像成像和应用案例的最新临床文献。

结论强调需要製定整合策略。

总之，超音波凝胶产业正处于一个转折点，配方科学、监管要求和供应链设计在此交汇融合，重新定义了竞争优势。投资于无菌生产能力、丰富黏度和成分产品线、并增强区域供应韧性的製造商，将更有能力满足不断变化的临床需求和采购需求。同时，医疗系统和经销商也将受益于与供应商的伙伴关係，这些供应商能够提供透明的品质文件、可靠的物流以及针对临床实践和介入流程量身定制的产品系列。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：超音波凝胶市场：依产品类型划分

  • 非无菌凝胶
  • 消毒凝胶

第九章：超音波凝胶市场

  • 高黏度
  • 低黏度
  • 中等黏度

第十章：超音波凝胶市场

  • 酒精凝胶
  • 芦荟凝胶
  • 水基凝胶

第十一章：超音波凝胶市场：依应用领域划分

  • 医学诊断
  • 治疗性超音波
  • 兽医应用

第十二章：超音波凝胶市场：依最终用户划分

  • 诊所
  • 诊断影像中心
  • 医院
  • 研究和学术机构

第十三章：超音波凝胶市场：按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章：超音波凝胶市场：依类别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章：超音波凝胶市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国超音波凝胶市场

第十七章：中国超音波凝胶市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • AiM Medical Technologies, LLC
  • Aquasonic Ultrasound Gels Inc.
  • Cardinal Health, Inc.
  • Ceracarta SpA
  • Compass Health Brands
  • EDM Medical Solutions
  • General Electric Company
  • HR Pharmaceuticals, Inc.
  • Jorgensen Laboratories, LLC
  • Medline Industries, Inc.
  • NEXT Medical Products Company
  • NIHON KOHDEN CORPORATION
  • PW Coole & Son Ltd Trading
  • Parker Laboratories Inc.
  • Phyto Performance Italia srl
  • Rohde Produits
  • Safersonic
  • Steroplast Healthcare Limited
  • Telic Group
  • Trivitron Healthcare Pvt. Ltd
  • Turkuaz Health
Product Code: MRR-A339DAEFA8F9

The Ultrasound Gels Market was valued at USD 149.00 million in 2025 and is projected to grow to USD 160.20 million in 2026, with a CAGR of 5.75%, reaching USD 220.46 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 149.00 million
Estimated Year [2026] USD 160.20 million
Forecast Year [2032] USD 220.46 million
CAGR (%) 5.75%

A nuanced introduction to the ultrasound gels industry landscape highlighting formulation, clinical integration, supply chain resilience, and regulatory attention

The global ultrasound gels landscape is evolving amid technological advances in imaging modalities, shifting clinical workflows, and heightened attention to infection prevention practices. Ultrasound gel functions as a critical, yet often overlooked, interface between transducers and tissue, and its formulation, viscosity, and sterility properties directly influence image quality, patient comfort, and procedural efficiency. As diagnostic and therapeutic ultrasound expand across point-of-care settings, outpatient clinics, and veterinary practices, demand patterns are adapting to new usage profiles and procurement priorities.

In addition, regulatory scrutiny around product labeling, biocompatibility, and sterility validation has intensified, prompting manufacturers to revisit ingredients and manufacturing controls. Supply chain resilience has emerged as a core operational priority following recent geopolitical disruptions and raw material fluctuations, driving buyers to evaluate supplier diversification, inventory strategies, and regional sourcing options. Taken together, these trends set the stage for a report that examines product differentiation, clinical adoption dynamics, and strategic responses by manufacturers and health systems, with an emphasis on actionable insights for stakeholders seeking to align product portfolios with evolving clinical needs.

Major structural shifts reshaping product innovation, sterility practices, and procurement preferences across clinical and veterinary ultrasound applications

The ultrasound gels sector is experiencing transformative shifts driven by convergence across technology, regulatory focus, and end-user expectations. Imaging systems with higher-frequency transducers and portable point-of-care devices are raising performance thresholds for gels, catalyzing innovation in viscosity modulation and ingredient selection to optimize acoustic coupling. Meanwhile, infection prevention imperatives and single-use device strategies are accelerating interest in sterile formulations and dispensing formats that minimize cross-contamination risk and support streamlined clinical workflows.

Concurrently, sustainability and ingredient transparency are influencing procurement choices, prompting manufacturers to explore aqueous-based and aloe-based formulations that balance performance with environmental and safety considerations. The rise of therapeutic ultrasound applications and veterinary usages is widening the product scope, encouraging multi-purpose gel designs and packaging variants. As these dynamics play out, manufacturers and health systems are re-evaluating value propositions to meet both clinical performance requirements and the operational constraints of modern care delivery. Consequently, competitive differentiation increasingly hinges on formulation science, regulatory compliance readiness, and the agility to respond to shifting procurement criteria.

Assessment of the 2025 United States tariff implications on raw materials and supply chain configurations driving procurement and localization responses

The United States tariff environment implemented in 2025 has introduced additional complexity for manufacturers, distributors, and health systems that rely on transnational supply chains for raw materials and finished gel products. Tariff impositions on certain polymeric additives, surfactants, and packaging components have elevated input cost pressures and prompted contract renegotiations. In response, supply chain stakeholders have intensified efforts to localize sourcing, adjust safety stocks, and reassess supplier qualification processes to hedge against further policy volatility.

This policy-driven cost vector has also affected decisions around manufacturing footprint optimization, with some producers accelerating investments in domestic processing capacity to reduce exposure to cross-border levies. At the same time, distributors and institutional buyers are exploring collaborative procurement arrangements and longer-term contracting to lock in pricing and assure continuity of supply. While short-term operational impacts include higher landed costs and friction in procurement cycles, the medium-term consequence is a reconfiguration of supplier networks and an increased emphasis on supply chain transparency, dual-sourcing strategies, and regional manufacturing resilience to mitigate policy uncertainty.

In-depth segmentation insights revealing product type, viscosity, ingredient base, application and end-user dynamics that drive targeted product strategies

Segment-level analysis reveals distinct performance and adoption patterns across formulation and usage categories that shape product strategy and commercialization priorities. Based on product type, Non-Sterile Gels remain predominant in routine diagnostic imaging where cost and ease of use are prioritized, while Sterile Gels are gaining traction in interventional procedures, perioperative settings, and any context where invasive devices or compromised skin integrity heighten infection risk. Based on viscosity level, High Viscosity formulations are favored for better adherence on vertical surfaces and prolonged procedures, Medium Viscosity options strike a balance for general diagnostic use, and Low Viscosity gels are selected for applications requiring rapid probe movement or specific acoustic coupling characteristics.

Based on ingredient base, Alcohol-Based Gels offer rapid dry times and antiseptic properties for certain point-of-care contexts, Aloe-Based Gels emphasize patient comfort and natural ingredient positioning, and Aqueous-Based Gels provide predictable acoustic transmission and broad compatibility with a wide range of transducer types. Based on application, Medical Diagnostics drives large-volume demand with emphasis on image clarity and consistency, Therapeutic Ultrasound demands gels tailored for energy transmission and skin compatibility, and Veterinary Applications require robust formulations that accommodate animal anatomy and handling considerations. Based on end-user, Clinics and Diagnostic Imaging Centers often prioritize cost-effectiveness and operational convenience, Hospitals focus on sterility, regulatory compliance, and supplier reliability, and Research & Academic Institutes value customizable formulations and precise performance characteristics. These segmentation insights inform targeted product development, differentiated go-to-market approaches, and tailored regulatory strategies to meet specific clinical and operational needs.

Regional commercial and regulatory dynamics across the Americas, Europe Middle East & Africa, and Asia-Pacific shaping sourcing, compliance, and distribution strategies

Regional dynamics are shaping sourcing approaches, regulatory alignment, and commercialization strategies across three primary geographies. In the Americas, demand patterns are influenced by a large and diverse network of hospitals and outpatient clinics that emphasize sterility standards, cost containment, and rapid adoption of point-of-care innovations, while procurement frameworks often favor consolidated supplier agreements and value-based purchasing models. In Europe, Middle East & Africa, regulatory complexity and heterogeneous reimbursement landscapes produce differentiated adoption curves, with certain markets emphasizing ingredient transparency, sustainability, and compliance with region-specific medical device directives, and emerging markets in the region presenting growth opportunities for competitively positioned manufacturers.

In the Asia-Pacific region, rapid expansion of diagnostic capacity, significant investments in healthcare infrastructure, and a growing private clinic sector drive demand for both standard diagnostic gels and specialized formulations. Supply chain strategies in this region emphasize manufacturing scale, local regulatory certification, and logistics efficiency to serve high-volume, price-sensitive channels. Across all regions, cross-border regulatory harmonization efforts, public procurement reforms, and evolving clinical guidelines contribute to the strategic calculus for product launches, regional manufacturing footprint decisions, and distributor partnerships. As stakeholders align regional commercial tactics with these dynamics, they can better navigate regulatory pathways and operational constraints to support sustainable growth and reliable supply.

Strategic competitive overview highlighting formulation differentiation, sterility validation, packaging innovation, and partnership opportunities across the industry

Competitive dynamics in the ultrasound gels sector reflect a mix of legacy manufacturers, specialty chemical formulators, and contract manufacturers that provide private-label solutions to clinical purchasers and distributors. Leading industry players are prioritizing formulation differentiation, sterility validation protocols, and packaging innovations that enhance single-use handling and reduce contamination risk. Partnerships with imaging OEMs for co-branded consumables and integrations with sterile procedural kits are emerging as strategic routes to secure recurring demand and strengthen channel relationships.

Investment in quality systems, cleanroom manufacturing, and third-party certification is becoming a core differentiator as procurement teams increasingly scrutinize supplier quality evidence and compliance records. At the same time, nimble niche players are using ingredient transparency, sustainable sourcing claims, and customer-focused service models to capture specialized segments such as veterinary channels or research institutions. For investors and corporate development teams, acquisition targets frequently include firms with unique formulation IP, regional manufacturing presence, or established distribution networks that can accelerate market entry and broaden product portfolios. Overall, the company landscape favors those who align product performance with demonstrable clinical benefits and operational reliability.

Actionable strategic recommendations focused on sterile capability expansion, portfolio modularity, supply chain diversification, and partnership-driven commercialization

Industry leaders should pursue a coordinated approach that links formulation innovation, regulatory preparedness, and supply chain resilience to maintain competitive advantage. First, prioritize investment in sterile formulation capabilities and validated packaging formats to support interventional and perioperative use cases, thereby addressing heightened infection prevention requirements and expanding into higher-value clinical segments. Next, develop a modular product portfolio that spans high, medium, and low viscosity options and leverages multiple ingredient bases to meet nuanced clinical preferences while enabling streamlined manufacturing flexibility.

In parallel, accelerate supplier diversification and regional manufacturing options to reduce exposure to policy-driven input cost shifts and to meet customers' demand for shorter lead times. Engage proactively with regulatory stakeholders to secure timely certifications and to align labeling with evolving safety and sustainability expectations. Finally, pursue selective partnerships with imaging system manufacturers and clinical service providers to embed gels into bundled offerings, creating stickier commercial relationships and clearer channels for product differentiation. Executed together, these actions will strengthen market positioning, enhance operational resilience, and create pathways to capture new clinical use cases.

Rigorous mixed-methods research methodology combining stakeholder interviews, regulatory review, and secondary evidence synthesis with quality assurance checks

This research synthesis draws on a structured approach combining primary and secondary inputs to ensure a robust and defensible evidence base. Primary inputs included interviews with clinical procurement leaders, imaging department managers, formulation scientists, and supply chain executives to surface current priorities, pain points, and operational constraints. These firsthand perspectives were complemented by a review of regulatory guidance, standards for biocompatibility and sterility, and recent clinical literature exploring ultrasound imaging and therapeutic use cases.

Secondary analysis incorporated trade publications, patent filings, formulation whitepapers, and publicly available regulatory filings to map technological innovations and competitive activity. The methodology emphasized triangulation across multiple data streams to validate trends and to contextualize strategic implications. Quality assurance protocols included cross-validation of interview findings, consistency checks against regulatory documents, and an audit trail of source materials. This layered approach ensures that conclusions are grounded in both practitioner experience and documented evidence, enabling decision-makers to apply insights with confidence in operational and clinical settings.

Concluding synthesis emphasizing the imperative of integrated strategies across formulation innovation, regulatory compliance, and supply chain resilience

In conclusion, the ultrasound gels sector is at an inflection point where formulation science, regulatory expectations, and supply chain design converge to redefine competitive advantage. Manufacturers that invest in sterile manufacturing capabilities, diversify viscosity and ingredient offerings, and strengthen regional supply resilience will be better positioned to meet evolving clinical requirements and procurement preferences. Health systems and distributors, in turn, will benefit from supplier partnerships that provide transparent quality documentation, dependable logistics, and product portfolios aligned with point-of-care and interventional workflows.

Looking ahead, success in this space will depend on the ability to translate technical formulation benefits into clear clinical and operational value propositions, to navigate regulatory pathways proactively, and to build supply chains that can withstand policy and geopolitical shifts. Stakeholders that adopt an integrated strategy-balancing innovation, compliance, and commercial agility-will be best placed to capture opportunities across diagnostic, therapeutic, and veterinary applications while maintaining the trust of clinical end users.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Ultrasound Gels Market, by Product Type

  • 8.1. Non-Sterile Gels
  • 8.2. Sterile Gels

9. Ultrasound Gels Market, by Viscosity Level

  • 9.1. High Viscosity
  • 9.2. Low Viscosity
  • 9.3. Medium Viscosity

10. Ultrasound Gels Market, by Ingredient Base

  • 10.1. Alcohol-Based Gels
  • 10.2. Aloe-Based Gels
  • 10.3. Aqueous-Based Gels

11. Ultrasound Gels Market, by Application

  • 11.1. Medical Diagnostics
  • 11.2. Therapeutic Ultrasound
  • 11.3. Veterinary Applications

12. Ultrasound Gels Market, by End-User

  • 12.1. Clinics
  • 12.2. Diagnostic Imaging Centers
  • 12.3. Hospitals
  • 12.4. Research & Academic Institutes

13. Ultrasound Gels Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Ultrasound Gels Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Ultrasound Gels Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Ultrasound Gels Market

17. China Ultrasound Gels Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. AiM Medical Technologies, LLC
  • 18.6. Aquasonic Ultrasound Gels Inc.
  • 18.7. Cardinal Health, Inc.
  • 18.8. Ceracarta S.p.A.
  • 18.9. Compass Health Brands
  • 18.10. EDM Medical Solutions
  • 18.11. General Electric Company
  • 18.12. HR Pharmaceuticals, Inc.
  • 18.13. Jorgensen Laboratories, LLC
  • 18.14. Medline Industries, Inc.
  • 18.15. NEXT Medical Products Company
  • 18.16. NIHON KOHDEN CORPORATION
  • 18.17. P.W. Coole & Son Ltd Trading
  • 18.18. Parker Laboratories Inc.
  • 18.19. Phyto Performance Italia srl
  • 18.20. Rohde Produits
  • 18.21. Safersonic
  • 18.22. Steroplast Healthcare Limited
  • 18.23. Telic Group
  • 18.24. Trivitron Healthcare Pvt. Ltd
  • 18.25. Turkuaz Health

LIST OF FIGURES

  • FIGURE 1. GLOBAL ULTRASOUND GELS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ULTRASOUND GELS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ULTRASOUND GELS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ULTRASOUND GELS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ULTRASOUND GELS MARKET SIZE, BY VISCOSITY LEVEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ULTRASOUND GELS MARKET SIZE, BY INGREDIENT BASE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ULTRASOUND GELS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ULTRASOUND GELS MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ULTRASOUND GELS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ULTRASOUND GELS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ULTRASOUND GELS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES ULTRASOUND GELS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA ULTRASOUND GELS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ULTRASOUND GELS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ULTRASOUND GELS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ULTRASOUND GELS MARKET SIZE, BY NON-STERILE GELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ULTRASOUND GELS MARKET SIZE, BY NON-STERILE GELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ULTRASOUND GELS MARKET SIZE, BY NON-STERILE GELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ULTRASOUND GELS MARKET SIZE, BY STERILE GELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ULTRASOUND GELS MARKET SIZE, BY STERILE GELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ULTRASOUND GELS MARKET SIZE, BY STERILE GELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ULTRASOUND GELS MARKET SIZE, BY VISCOSITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ULTRASOUND GELS MARKET SIZE, BY HIGH VISCOSITY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ULTRASOUND GELS MARKET SIZE, BY HIGH VISCOSITY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ULTRASOUND GELS MARKET SIZE, BY HIGH VISCOSITY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ULTRASOUND GELS MARKET SIZE, BY LOW VISCOSITY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ULTRASOUND GELS MARKET SIZE, BY LOW VISCOSITY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ULTRASOUND GELS MARKET SIZE, BY LOW VISCOSITY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ULTRASOUND GELS MARKET SIZE, BY MEDIUM VISCOSITY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ULTRASOUND GELS MARKET SIZE, BY MEDIUM VISCOSITY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ULTRASOUND GELS MARKET SIZE, BY MEDIUM VISCOSITY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ULTRASOUND GELS MARKET SIZE, BY INGREDIENT BASE, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ULTRASOUND GELS MARKET SIZE, BY ALCOHOL-BASED GELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ULTRASOUND GELS MARKET SIZE, BY ALCOHOL-BASED GELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ULTRASOUND GELS MARKET SIZE, BY ALCOHOL-BASED GELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ULTRASOUND GELS MARKET SIZE, BY ALOE-BASED GELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ULTRASOUND GELS MARKET SIZE, BY ALOE-BASED GELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ULTRASOUND GELS MARKET SIZE, BY ALOE-BASED GELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ULTRASOUND GELS MARKET SIZE, BY AQUEOUS-BASED GELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ULTRASOUND GELS MARKET SIZE, BY AQUEOUS-BASED GELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ULTRASOUND GELS MARKET SIZE, BY AQUEOUS-BASED GELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ULTRASOUND GELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ULTRASOUND GELS MARKET SIZE, BY MEDICAL DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ULTRASOUND GELS MARKET SIZE, BY MEDICAL DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ULTRASOUND GELS MARKET SIZE, BY MEDICAL DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ULTRASOUND GELS MARKET SIZE, BY THERAPEUTIC ULTRASOUND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ULTRASOUND GELS MARKET SIZE, BY THERAPEUTIC ULTRASOUND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ULTRASOUND GELS MARKET SIZE, BY THERAPEUTIC ULTRASOUND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ULTRASOUND GELS MARKET SIZE, BY VETERINARY APPLICATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ULTRASOUND GELS MARKET SIZE, BY VETERINARY APPLICATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ULTRASOUND GELS MARKET SIZE, BY VETERINARY APPLICATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ULTRASOUND GELS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ULTRASOUND GELS MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ULTRASOUND GELS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ULTRASOUND GELS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ULTRASOUND GELS MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ULTRASOUND GELS MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ULTRASOUND GELS MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ULTRASOUND GELS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ULTRASOUND GELS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ULTRASOUND GELS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ULTRASOUND GELS MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ULTRASOUND GELS MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ULTRASOUND GELS MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ULTRASOUND GELS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. AMERICAS ULTRASOUND GELS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 54. AMERICAS ULTRASOUND GELS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 55. AMERICAS ULTRASOUND GELS MARKET SIZE, BY VISCOSITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 56. AMERICAS ULTRASOUND GELS MARKET SIZE, BY INGREDIENT BASE, 2018-2032 (USD MILLION)
  • TABLE 57. AMERICAS ULTRASOUND GELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 58. AMERICAS ULTRASOUND GELS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 59. NORTH AMERICA ULTRASOUND GELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. NORTH AMERICA ULTRASOUND GELS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 61. NORTH AMERICA ULTRASOUND GELS MARKET SIZE, BY VISCOSITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 62. NORTH AMERICA ULTRASOUND GELS MARKET SIZE, BY INGREDIENT BASE, 2018-2032 (USD MILLION)
  • TABLE 63. NORTH AMERICA ULTRASOUND GELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 64. NORTH AMERICA ULTRASOUND GELS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 65. LATIN AMERICA ULTRASOUND GELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. LATIN AMERICA ULTRASOUND GELS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 67. LATIN AMERICA ULTRASOUND GELS MARKET SIZE, BY VISCOSITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 68. LATIN AMERICA ULTRASOUND GELS MARKET SIZE, BY INGREDIENT BASE, 2018-2032 (USD MILLION)
  • TABLE 69. LATIN AMERICA ULTRASOUND GELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 70. LATIN AMERICA ULTRASOUND GELS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 71. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND GELS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 72. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND GELS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND GELS MARKET SIZE, BY VISCOSITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 74. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND GELS MARKET SIZE, BY INGREDIENT BASE, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND GELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND GELS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE ULTRASOUND GELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE ULTRASOUND GELS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE ULTRASOUND GELS MARKET SIZE, BY VISCOSITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE ULTRASOUND GELS MARKET SIZE, BY INGREDIENT BASE, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE ULTRASOUND GELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE ULTRASOUND GELS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 83. MIDDLE EAST ULTRASOUND GELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. MIDDLE EAST ULTRASOUND GELS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. MIDDLE EAST ULTRASOUND GELS MARKET SIZE, BY VISCOSITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 86. MIDDLE EAST ULTRASOUND GELS MARKET SIZE, BY INGREDIENT BASE, 2018-2032 (USD MILLION)
  • TABLE 87. MIDDLE EAST ULTRASOUND GELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 88. MIDDLE EAST ULTRASOUND GELS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 89. AFRICA ULTRASOUND GELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. AFRICA ULTRASOUND GELS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. AFRICA ULTRASOUND GELS MARKET SIZE, BY VISCOSITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 92. AFRICA ULTRASOUND GELS MARKET SIZE, BY INGREDIENT BASE, 2018-2032 (USD MILLION)
  • TABLE 93. AFRICA ULTRASOUND GELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 94. AFRICA ULTRASOUND GELS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC ULTRASOUND GELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC ULTRASOUND GELS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC ULTRASOUND GELS MARKET SIZE, BY VISCOSITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC ULTRASOUND GELS MARKET SIZE, BY INGREDIENT BASE, 2018-2032 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC ULTRASOUND GELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC ULTRASOUND GELS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL ULTRASOUND GELS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. ASEAN ULTRASOUND GELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. ASEAN ULTRASOUND GELS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. ASEAN ULTRASOUND GELS MARKET SIZE, BY VISCOSITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 105. ASEAN ULTRASOUND GELS MARKET SIZE, BY INGREDIENT BASE, 2018-2032 (USD MILLION)
  • TABLE 106. ASEAN ULTRASOUND GELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 107. ASEAN ULTRASOUND GELS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 108. GCC ULTRASOUND GELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GCC ULTRASOUND GELS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. GCC ULTRASOUND GELS MARKET SIZE, BY VISCOSITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 111. GCC ULTRASOUND GELS MARKET SIZE, BY INGREDIENT BASE, 2018-2032 (USD MILLION)
  • TABLE 112. GCC ULTRASOUND GELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. GCC ULTRASOUND GELS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPEAN UNION ULTRASOUND GELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPEAN UNION ULTRASOUND GELS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPEAN UNION ULTRASOUND GELS MARKET SIZE, BY VISCOSITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPEAN UNION ULTRASOUND GELS MARKET SIZE, BY INGREDIENT BASE, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPEAN UNION ULTRASOUND GELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPEAN UNION ULTRASOUND GELS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 120. BRICS ULTRASOUND GELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. BRICS ULTRASOUND GELS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. BRICS ULTRASOUND GELS MARKET SIZE, BY VISCOSITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 123. BRICS ULTRASOUND GELS MARKET SIZE, BY INGREDIENT BASE, 2018-2032 (USD MILLION)
  • TABLE 124. BRICS ULTRASOUND GELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 125. BRICS ULTRASOUND GELS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 126. G7 ULTRASOUND GELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. G7 ULTRASOUND GELS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. G7 ULTRASOUND GELS MARKET SIZE, BY VISCOSITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 129. G7 ULTRASOUND GELS MARKET SIZE, BY INGREDIENT BASE, 2018-2032 (USD MILLION)
  • TABLE 130. G7 ULTRASOUND GELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. G7 ULTRASOUND GELS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 132. NATO ULTRASOUND GELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. NATO ULTRASOUND GELS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. NATO ULTRASOUND GELS MARKET SIZE, BY VISCOSITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 135. NATO ULTRASOUND GELS MARKET SIZE, BY INGREDIENT BASE, 2018-2032 (USD MILLION)
  • TABLE 136. NATO ULTRASOUND GELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. NATO ULTRASOUND GELS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL ULTRASOUND GELS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. UNITED STATES ULTRASOUND GELS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 140. UNITED STATES ULTRASOUND GELS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. UNITED STATES ULTRASOUND GELS MARKET SIZE, BY VISCOSITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 142. UNITED STATES ULTRASOUND GELS MARKET SIZE, BY INGREDIENT BASE, 2018-2032 (USD MILLION)
  • TABLE 143. UNITED STATES ULTRASOUND GELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. UNITED STATES ULTRASOUND GELS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 145. CHINA ULTRASOUND GELS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 146. CHINA ULTRASOUND GELS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. CHINA ULTRASOUND GELS MARKET SIZE, BY VISCOSITY LEVEL, 2018-2032 (USD MILLION)
  • TABLE 148. CHINA ULTRASOUND GELS MARKET SIZE, BY INGREDIENT BASE, 2018-2032 (USD MILLION)
  • TABLE 149. CHINA ULTRASOUND GELS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. CHINA ULTRASOUND GELS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)